In animals bearing LuCaP 93 tumors, cabozantinib treatment significantly decreased tumor volume (TV) in MET+/RET+ LuCaP 93 animals compared to vehicle controls (p = 0.0175; Fig 3A). The gene discussed is MET; the disease is neoplasm.